Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Other Non-Current Liabilities (2023 - 2025)

PAVmed has reported Other Non-Current Liabilities over the past 3 years, most recently at $6.9 million for Q3 2025.

  • Quarterly results put Other Non-Current Liabilities at $6.9 million for Q3 2025, changed N/A from a year ago — trailing twelve months through Sep 2025 was $6.9 million (changed N/A YoY), and the annual figure for FY2024 was $29.1 million, down 34.16%.
  • Other Non-Current Liabilities for Q3 2025 was $6.9 million at PAVmed, up from $6.8 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for PAVM hit a ceiling of $44.2 million in Q4 2023 and a floor of $260000.0 in Q2 2023.
  • Median Other Non-Current Liabilities over the past 3 years was $6.8 million (2025), compared with a mean of $13.5 million.
  • Peak annual rise in Other Non-Current Liabilities hit 34.16% in 2024, while the deepest fall reached 34.16% in 2024.
  • PAVmed's Other Non-Current Liabilities stood at $44.2 million in 2023, then plummeted by 34.16% to $29.1 million in 2024, then tumbled by 76.29% to $6.9 million in 2025.
  • The last three reported values for Other Non-Current Liabilities were $6.9 million (Q3 2025), $6.8 million (Q2 2025), and $6.6 million (Q1 2025) per Business Quant data.